Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $1.29 billion. The enterprise value is $1.94 billion.
Important Dates
The last earnings date was Thursday, October 9, 2025, before market open.
| Earnings Date | Oct 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 217.30 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | 217.30M |
| Shares Outstanding | 217.30M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.51% |
| Owned by Institutions (%) | 112.80% |
| Float | 205.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.31 |
| PS Ratio | 1.45 |
| Forward PS | 1.54 |
| PB Ratio | 0.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.78 |
| PEG Ratio | 1.83 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.19 |
| EV / EBITDA | 19.27 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.38.
| Current Ratio | 3.58 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 7.38 |
| Debt / FCF | n/a |
| Interest Coverage | -0.26 |
Financial Efficiency
Return on equity (ROE) is -39.71% and return on invested capital (ROIC) is -0.32%.
| Return on Equity (ROE) | -39.71% |
| Return on Assets (ROA) | -0.28% |
| Return on Invested Capital (ROIC) | -0.32% |
| Return on Capital Employed (ROCE) | -0.56% |
| Revenue Per Employee | $298,213 |
| Profits Per Employee | -$350,739 |
| Employee Count | 2,974 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 2.43 |
Taxes
| Income Tax | -30.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.45% in the last 52 weeks. The beta is 1.98, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | -59.45% |
| 50-Day Moving Average | 5.94 |
| 200-Day Moving Average | 6.45 |
| Relative Strength Index (RSI) | 44.48 |
| Average Volume (20 Days) | 3,334,464 |
Short Selling Information
The latest short interest is 23.14 million, so 10.65% of the outstanding shares have been sold short.
| Short Interest | 23.14M |
| Short Previous Month | 22.93M |
| Short % of Shares Out | 10.65% |
| Short % of Float | 11.28% |
| Short Ratio (days to cover) | 4.70 |
Income Statement
In the last 12 months, Neogen had revenue of $886.89 million and -$1.04 billion in losses. Loss per share was -$4.81.
| Revenue | 886.89M |
| Gross Profit | 411.42M |
| Operating Income | -17.97M |
| Pretax Income | -1.07B |
| Net Income | -1.04B |
| EBITDA | 100.77M |
| EBIT | -17.97M |
| Loss Per Share | -$4.81 |
Full Income StatementBalance Sheet
The company has $138.88 million in cash and $794.72 million in debt, giving a net cash position of -$655.84 million or -$3.02 per share.
| Cash & Cash Equivalents | 138.88M |
| Total Debt | 794.72M |
| Net Cash | -655.84M |
| Net Cash Per Share | -$3.02 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 9.75 |
| Working Capital | 377.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $87.01 million and capital expenditures -$90.16 million, giving a free cash flow of -$3.15 million.
| Operating Cash Flow | 87.01M |
| Capital Expenditures | -90.16M |
| Free Cash Flow | -3.15M |
| FCF Per Share | -$0.01 |
Full Cash Flow StatementMargins
Gross margin is 46.39%, with operating and profit margins of -2.03% and -117.61%.
| Gross Margin | 46.39% |
| Operating Margin | -2.03% |
| Pretax Margin | -121.06% |
| Profit Margin | -117.61% |
| EBITDA Margin | 11.36% |
| EBIT Margin | -2.03% |
| FCF Margin | n/a |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.21% |
| Shareholder Yield | -0.21% |
| Earnings Yield | -81.09% |
| FCF Yield | -0.25% |
Dividend DetailsAnalyst Forecast
The average price target for Neogen is $8.83, which is 49.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.83 |
| Price Target Difference | 49.16% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 1.08% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 1.18 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.18 |
| Piotroski F-Score | 4 |
